64.81
Finanzdaten der Anaptysbio Inc-Aktie (ANAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
41.84%
108.25
|
76.32 | 22.26 | 27.77 | 30.02 |
| Operating Expenses |
0.64%
41.35
|
41.62 | 48.43 | 55.31 | 52.77 |
| Benefits Costs and Expenses |
4.33%
58.55
|
61.21 | 60.85 | 67.06 | 62.87 |
| Costs And Expenses |
4.33%
58.55
|
61.21 | 60.85 | 67.06 | 62.87 |
| Operating Income/Loss |
92.78%
66.90
|
34.70 | -26.17 | -27.54 | -22.76 |
| Nonoperating Income/Loss |
12.17%
-17.21
|
-19.59 | -12.42 | -11.75 | -10.09 |
| Income/Loss From Continuing Operations Before Tax |
228.82%
49.70
|
15.11 | -38.59 | -39.28 | -32.85 |
| Income Tax Expense/Benefit |
0.081
|
- | 0.039 | 0.044 | - |
| Income/Loss From Continuing Operations After Tax |
228.29%
49.61
|
15.11 | -38.63 | -39.33 | -32.85 |
|
|
228.29%
49.61
|
15.11 | -38.63 | -39.33 | -32.85 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
101.17%
-0.327
|
27.83 | 28.81 | 30.64 | 28.89 |
| Diluted Average Shares |
101.13%
-0.327
|
29.02 | 28.81 | 30.64 | 28.89 |
| Basic Earnings Per Share |
214.81%
1.70
|
0.54 | -1.34 | -1.28 | -1.14 |
| Diluted Earnings Per Share |
226.92%
1.70
|
0.52 | -1.34 | -1.28 | -1.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):